Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB01037
http://purl.obolibrary.org/obo/dinto_DB01037
|
|---|---|
| Preferred Name | selegiline |
| Synonyms |
C13H17N
methyl(1-phenylpropan-2-yl)(prop-2-yn-1-yl)amine
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | selegiline
|
|---|---|
| label | selegiline
|
| DBSynonym |
l-deprenalin
selegilinum [inn-latin]
selegeline hcl
selegilina [inn-spanish]
|
| ATCCode | N04BD01
|
| Definition | A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson s disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl. [PubChem]
|
| has effect |
See more
See less
|
| has pharmacological target | |
| inhibits |
See more
See less
|
| type | |
| InChIKey | InChIKey=MEZLKOACVSPNER-UHFFFAOYSA-N
|
| is metabolised by |
See more
See less
|
| AHFScode |
92:00.00
28:92.00
|
| Synonym |
C13H17N
methyl(1-phenylpropan-2-yl)(prop-2-yn-1-yl)amine
|
| xref |
ChEBI:50217
Drugs Product Database (DPD):2238340
RxList:http://www.rxlist.com/cgi/generic/seleg.htm
Drugs.com:http://www.drugs.com/cdi/selegiline.html
National Drug Code Directory:0378-9290-91
PharmGKB:PA451316
BindingDB:15579
Wikipedia:http://en.wikipedia.org/wiki/Selegiline
See more
See less
|
| CASRN | 14611-51-9
|
| prefixIRI | obo2:dinto_DB01037
|
| SMILES | CC(CC1=CC=CC=C1)N(C)CC#C
|
| may interact with |
See more
See less
|
| InChI | InChI=1S/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3
|
| DBBrand |
carbex
novo-selegiline
emsam
gen-selegiline
sd deprenyl
apo-selegiline
eldepryl
nu-selegiline
jumex
zelapar
See more
See less
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |